Professor Richard Gilbertson elected as Fellow of the Royal Society

Congratulations to Richard Gilbertson, research lead for the Cambridge Cancer Research Hospital, on being recognised for his scientific excellence.

He joins over 60 exceptional scientists from around the world honoured by the Royal Society this year. Richard Gilbertson is one of nine leading researchers from the University of Cambridge to be elected into the Fellowship of the Royal Society. He said:

I am truly delighted and humbled to receive this recognition that I share with all the wonderful students, trainees and colleagues I have worked with over the years.

Richard Gilbertson is a paediatric physician-scientist. He is Li Ka Shing Chair of Oncology and Head of Department of Oncology at the University of Cambridge, Director of Cancer Research UK Cambridge Centre and Senior Group Leader, CRUK Cambridge Institute.

He is also Joint Delivery Board co-chair and research lead for the Cambridge Cancer Research Hospital, which will bring together clinical expertise at Addenbrooke’s Hospital with world-class scientists across the University of Cambridge and the Cancer Research UK Cambridge Centre. Together, they will work in the heart of new clinic and hospital spaces, bringing the research bench to the bedside.

Professor Gilbertson's laboratory research is focused on understanding the link between normal development and the origins of cancer, particularly children's brain tumours.

He has identified the origins of common and aggressive childhood brain tumours and many of the genetic alterations that drive these tumours.

His world-leading research has helped establish a direct link between disordered development and the multiple different brain tumour types observed in children: contributing directly to their classification by the World Health Organisation (WHO); changing the way conventional treatments are used, sparing children from unnecessary side effects; and underpinning clinical trials of new therapies.

The 51 Fellows and 10 Foreign Members along with one Honorary Fellow have been selected for their outstanding contributions to science. Their work spans multiple disciplines, from using AI to better detect strokes to developing new technologies for improved energy storage and expanding our understanding of genetic cancer risk factors in non-European populations.

Sir Adrian Smith, President of the Royal Society said:

It is an honour to welcome so many outstanding researchers from around the world into the Fellowship of the Royal Society. Through their careers so far, these researchers have helped further our understanding of human disease, biodiversity loss and the origins of the universe.

Read about all of this year's Fellows on the Royal Society website